Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma
Clinical trial NCT03437070 · WITHDRAWN
Trial details
- NCT number
- NCT03437070
- Sponsor
- University of Miami
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-01
- Primary completion
- 2021-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.